INSTITUTE OF CHEMICAL TECHNOLOGY BE LJNIVERSITY LINDER SECTION - 3 OF UGC ACT-(1956) TO DEEMED First Elite status & centre of Excellence - Govt. of Maharashtra category I Institute, MHRDruGC (2018) 'A+ Grade bY NAAC (CGPA 3.7CI
III Funded 4OO 019 MUMBAI MATI"]NGA, TEQIP
Date: December 18,2019 Advertisement Applications are invited for the post of Junior Research Fellods Project Title
Innovative Parenteral Formulations
Sponsor
Amaterasu Lifesciences LLP
Principle Investigator
hof.
No. of Positions
Upto Two M Pharm. Candidates must be conversant with latest trends in
Qualifi cations and experience
Remuneration/FellowshiP
Padma V. Devarajan
parenteral DDS. Candidates must preferably have experience in animal
:
handling and industrial experience in formulation development, preferably of parenteral formulations Rs 3 1,000/= plus HRA (24 %) as applicable per month, for the first two years to be increased in the next two years based on progress.
The project fellow will be appointed initially for one year and the tenure may be extended based on performance for the subsequent period. All appointments are terminated with end of the project. Selected fellows will be permitted to register for PhD(Tech) under the supervision of Prof. Padma V. Devarajan, in keeping withthe rules of ICT :.
.
Interested candidates should send their applications including cover letter, Curriculum vitae by email (research.assistant@staff.ictmumbai.edu.in). Please mention in the subject of email "Application for the post of Junior Research Fellow ProjectName Innovative Parenteral Formulations" The applications thould reach before January lO, 2020, along with cover letter, Cuniculum vitae. Candidates who apply are requested to attend the interview.
will be held on Tuesday, January 15,2O2O at 2.30 pm in Pharma Conference Room, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technolory, Matunga, Mumbai 400019. Selection will be based on an interview conducted by a committee. The recommendation oi"th..o*-ittee will be final.
The interviews
No TA/DA will be provided to appear for this interview. Registrar